Ohara D, Takeuchi Y, Hirota K
Cell Mol Immunol. 2024; 21(11):1183-1200.
PMID: 39379604
PMC: 11528014.
DOI: 10.1038/s41423-024-01218-x.
Kozu K, do Nascimento R, Aires P, Cordeiro R, de Moura T, Sztajnbok F
Adv Rheumatol. 2024; 64(1):62.
PMID: 39175060
DOI: 10.1186/s42358-024-00404-9.
Griffin H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, Davies S, Loo P
N Engl J Med. 2024; 391(5):434-441.
PMID: 39083772
PMC: 7616361.
DOI: 10.1056/NEJMoa2312302.
Aschenbrenner D, Nassiri I, Venkateswaran S, Pandey S, Page M, Drowley L
Nat Commun. 2024; 15(1):4529.
PMID: 38806456
PMC: 11133462.
DOI: 10.1038/s41467-024-47218-3.
Marafini I, Monteleone I, Laudisi F, Monteleone G
Int J Mol Sci. 2024; 25(8).
PMID: 38674118
PMC: 11050475.
DOI: 10.3390/ijms25084527.
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards.
Uhlig H, Booth C, Cho J, Dubinsky M, Griffiths A, Grimbacher B
Nat Rev Gastroenterol Hepatol. 2023; 20(12):810-828.
PMID: 37789059
DOI: 10.1038/s41575-023-00838-4.
Intestinal Immune Imbalance is an Alarm in the Development of IBD.
Hu C, Liao S, Lv L, Li C, Mei Z
Mediators Inflamm. 2023; 2023:1073984.
PMID: 37554552
PMC: 10406561.
DOI: 10.1155/2023/1073984.
Interleukin-10 in cancer immunotherapy: from bench to bedside.
Salkeni M, Naing A
Trends Cancer. 2023; 9(9):716-725.
PMID: 37321942
PMC: 10524969.
DOI: 10.1016/j.trecan.2023.05.003.
Clinical Features and Genetic Analysis of Taiwanese Primary Immunodeficiency Patients with Prolonged Diarrhea and Monogenetic Inflammatory Bowel Disease.
Lee W, Chen C, Chen S, Lai W, Jaing T, Ou L
J Clin Immunol. 2023; 43(6):1455-1467.
PMID: 37202577
DOI: 10.1007/s10875-023-01503-w.
Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases.
Levine A, Mark D, Smith L, Zheng H, Suskind D
Pharmaceutics. 2023; 15(3).
PMID: 36986830
PMC: 10059893.
DOI: 10.3390/pharmaceutics15030969.
The IL-10 receptor inhibits cell extrinsic signals necessary for STAT1-dependent macrophage accumulation during colitis.
Patik I, Redhu N, Eran A, Bao B, Nandy A, Tang Y
Mucosal Immunol. 2023; 16(3):233-249.
PMID: 36868479
PMC: 10431098.
DOI: 10.1016/j.mucimm.2023.02.006.
The Potential Therapeutic Role of for Treatment of Inflammatory Bowel Disease.
Guo H, Yu L, Tian F, Chen W, Zhai Q
Foods. 2023; 12(4).
PMID: 36832767
PMC: 9955806.
DOI: 10.3390/foods12040692.
deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice.
Lopez-Cauce B, Puerto M, Garcia J, Ponce-Alonso M, Becerra-Aparicio F, Del Campo R
Front Microbiol. 2023; 13:1083884.
PMID: 36699599
PMC: 9869054.
DOI: 10.3389/fmicb.2022.1083884.
The ups and downs of STAT3 function: too much, too little and human immune dysregulation.
Mackie J, Ma C, Tangye S, Guerin A
Clin Exp Immunol. 2023; 212(2):107-116.
PMID: 36652220
PMC: 10128169.
DOI: 10.1093/cei/uxad007.
Inborn errors of immunity and related microbiome.
Hazime R, Eddehbi F, El Mojadili S, Lakhouaja N, Souli I, Salami A
Front Immunol. 2022; 13:982772.
PMID: 36177048
PMC: 9513548.
DOI: 10.3389/fimmu.2022.982772.
Clinical Characteristics, Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel Variants.
Chen Y, Chen J, Guo W, Zhang Y, Li J, Xie H
Front Genet. 2022; 13:921808.
PMID: 35783276
PMC: 9243236.
DOI: 10.3389/fgene.2022.921808.
Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.
Azabdaftari A, Jones K, Kammermeier J, Uhlig H
Hum Genet. 2022; 142(5):599-611.
PMID: 35761107
DOI: 10.1007/s00439-022-02464-7.
Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations.
Levine A, Zheng H, Suskind D
Paediatr Drugs. 2022; 24(3):207-216.
PMID: 35467244
DOI: 10.1007/s40272-022-00503-4.
New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease.
Li Q, Zhang H, Dai S
Front Pediatr. 2022; 10:714054.
PMID: 35299671
PMC: 8921506.
DOI: 10.3389/fped.2022.714054.
Activation pathways that drive CD4 T cells to break tolerance in autoimmune diseases.
Krovi S, Kuchroo V
Immunol Rev. 2022; 307(1):161-190.
PMID: 35142369
PMC: 9255211.
DOI: 10.1111/imr.13071.
